Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial

Peer Review reports

Original Submission
1 Feb 2022	Submitted	Original manuscript
4 Mar 2022	Reviewed	Reviewer Report - Takao Takeshima
6 Apr 2022	Reviewed	Reviewer Report
28 Apr 2022	Author responded	Author comments - Roger Cady
Resubmission - Version 2
28 Apr 2022	Submitted	Manuscript version 2
Publishing
11 May 2022	Editorially accepted
3 Jun 2022	Article published	10.1186/s12883-022-02714-1

Back to article page